Tower Research Capital (TRC)’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.95K | Sell |
1,103
-118
| -10% | -$851 | ﹤0.01% | 4029 |
|
|
2025
Q1 | $10.1K | Buy |
1,221
+569
| +87% | +$4.69K | ﹤0.01% | 3680 |
|
|
2024
Q4 | $26K | Buy |
652
+622
| +2,073% | +$24.8K | ﹤0.01% | 2985 |
|
|
2024
Q3 | $260 | Sell |
30
-1,829
| -98% | -$15.9K | ﹤0.01% | 5407 |
|
|
2024
Q2 | $16.3K | Buy |
1,859
+1,538
| +479% | +$13.5K | ﹤0.01% | 3868 |
|
|
2024
Q1 | $7.86K | Sell |
321
-428
| -57% | -$10.5K | ﹤0.01% | 4123 |
|
|
2023
Q4 | $12.4K | Buy |
+749
| New | +$12.4K | ﹤0.01% | 4043 |
|
|
2023
Q2 | – | Sell |
-4
| Closed | – | – | 5994 |
|
|
2023
Q1 | $0 | Buy |
+4
| New | – | ﹤0.01% | 5765 |
|
|
2022
Q4 | – | Sell |
-322
| Closed | -$9K | – | 5846 |
|
|
2022
Q3 | $9K | Sell |
322
-424
| -57% | -$11.9K | ﹤0.01% | 4629 |
|
|
2022
Q2 | $22K | Buy |
746
+550
| +281% | +$16.2K | ﹤0.01% | 3679 |
|
|
2022
Q1 | $11K | Buy |
196
+118
| +151% | +$6.62K | ﹤0.01% | 4138 |
|
|
2021
Q4 | $23K | Buy |
78
+43
| +123% | +$12.7K | ﹤0.01% | 3497 |
|
|
2021
Q3 | $14K | Sell |
35
-24
| -41% | -$9.6K | ﹤0.01% | 4018 |
|
|
2021
Q2 | $30K | Buy |
59
+27
| +84% | +$13.7K | ﹤0.01% | 3475 |
|
|
2021
Q1 | $18K | Buy |
32
+12
| +60% | +$6.75K | ﹤0.01% | 3952 |
|
|
2020
Q4 | $14K | Buy |
+20
| New | +$14K | ﹤0.01% | 4082 |
|